
Jan 18, 2025, 06:34
Intermittent versus continuous chemotherapy in advanced colorectal cancer
Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared on X:
Authors: A. Sobrero, L. Isa, E. Cortesi, S. Barni, D. Nicolella, M. Aglietta, S. Lonardi, D. Corsi, D. Turci, G.D. Beretta, G. Fornarini, E. Dapretto, I. Floriani, A. Zaniboni.
Intermittent FOLFIRI given on a 2 month on-off schedule doesn’t compromise PFS and OS in advanced colon cancer.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 30, 2025, 23:21
Mar 30, 2025, 18:52
Mar 30, 2025, 18:31